BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20094034)

  • 1. The intronic splicing code: multiple factors involved in ATM pseudoexon definition.
    Dhir A; Buratti E; van Santen MA; Lührmann R; Baralle FE
    EMBO J; 2010 Feb; 29(4):749-60. PubMed ID: 20094034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional studies on the ATM intronic splicing processing element.
    Lewandowska MA; Stuani C; Parvizpur A; Baralle FE; Pagani F
    Nucleic Acids Res; 2005; 33(13):4007-15. PubMed ID: 16030351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events.
    Buratti E; Dhir A; Lewandowska MA; Baralle FE
    Nucleic Acids Res; 2007; 35(13):4369-83. PubMed ID: 17580311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of SR45, an SR-like protein, with spliceosomal proteins and an intronic sequence: insights into regulated splicing.
    Day IS; Golovkin M; Palusa SG; Link A; Ali GS; Thomas J; Richardson DN; Reddy AS
    Plant J; 2012 Sep; 71(6):936-47. PubMed ID: 22563826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing.
    Pastor T; Pagani F
    PLoS One; 2011; 6(8):e23349. PubMed ID: 21858080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPL30 regulation of splicing reveals distinct roles for Cbp80 in U1 and U2 snRNP cotranscriptional recruitment.
    Bragulat M; Meyer M; Macías S; Camats M; Labrador M; Vilardell J
    RNA; 2010 Oct; 16(10):2033-41. PubMed ID: 20801768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.
    Eperon IC; Makarova OV; Mayeda A; Munroe SH; Cáceres JF; Hayward DG; Krainer AR
    Mol Cell Biol; 2000 Nov; 20(22):8303-18. PubMed ID: 11046128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM.
    Pastor T; Talotti G; Lewandowska MA; Pagani F
    Nucleic Acids Res; 2009 Nov; 37(21):7258-67. PubMed ID: 19773425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
    Damgaard CK; Tange TO; Kjems J
    RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U1 snRNP-ASF/SF2 interaction and 5' splice site recognition: characterization of required elements.
    Jamison SF; Pasman Z; Wang J; Will C; Lührmann R; Manley JL; Garcia-Blanco MA
    Nucleic Acids Res; 1995 Aug; 23(16):3260-7. PubMed ID: 7667103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional significance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a.
    Coutinho G; Xie J; Du L; Brusco A; Krainer AR; Gatti RA
    Hum Mutat; 2005 Feb; 25(2):118-24. PubMed ID: 15643608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRp30c is a repressor of 3' splice site utilization.
    Simard MJ; Chabot B
    Mol Cell Biol; 2002 Jun; 22(12):4001-10. PubMed ID: 12024014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to describe a U1 snRNA binding site.
    Freund M; Asang C; Kammler S; Konermann C; Krummheuer J; Hipp M; Meyer I; Gierling W; Theiss S; Preuss T; Schindler D; Kjems J; Schaal H
    Nucleic Acids Res; 2003 Dec; 31(23):6963-75. PubMed ID: 14627829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new type of mutation causes a splicing defect in ATM.
    Pagani F; Buratti E; Stuani C; Bendix R; Dörk T; Baralle FE
    Nat Genet; 2002 Apr; 30(4):426-9. PubMed ID: 11889466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-spliceosomal binding of U1 small nuclear ribonucleoprotein (RNP) and heterogenous nuclear RNP E1 is associated with suppression of a growth hormone receptor pseudoexon.
    Akker SA; Misra S; Aslam S; Morgan EL; Smith PJ; Khoo B; Chew SL
    Mol Endocrinol; 2007 Oct; 21(10):2529-40. PubMed ID: 17622584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
    Cao W; Garcia-Blanco MA
    J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation-dependent control of the pre-mRNA splicing machinery.
    Soret J; Tazi J
    Prog Mol Subcell Biol; 2003; 31():89-126. PubMed ID: 12494764
    [No Abstract]   [Full Text] [Related]  

  • 20. Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO).
    Cavalieri S; Pozzi E; Gatti RA; Brusco A
    Eur J Hum Genet; 2013 Jul; 21(7):774-8. PubMed ID: 23211698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.